In vivo protection of the pig liver against ischemia/reperfusion injury by tauroursodeoxycholate

Langenbeck's Archives of Surgery

Volumn 384, Issue 5, 1999, Pages 461-466

  Hertl, Martin ^a   Hertl, M Catherine ^a   Malagó, Massimo ^a   Broelsch, Christoph E ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Bile salt; Liver transplantation; Rat; Reperfusion injury; Tauroursodeoxycholate

Indexed keywords

BILE SALT; LIVER ENZYME; TAUROURSODEOXYCHOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE FLOW; CONTROLLED STUDY; ISCHEMIA; LIVER FUNCTION; LIVER PRESERVATION; LIVER PROTECTION; LIVER TRANSPLANTATION; MALE; MEMBRANE STABILIZATION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SURVIVAL RATE; SWINE;

ANALYSIS OF VARIANCE; ANIMALS; BILE ACIDS AND SALTS; CHOLAGOGUES AND CHOLERETICS; INFUSIONS, INTRAVENOUS; LIVER; LIVER TRANSPLANTATION; MALE; ORGAN PRESERVATION; REPERFUSION INJURY; SWINE; TAUROCHENODEOXYCHOLIC ACID;

EID: 0032739916     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004230050231     Document Type: Article

References (22)

1. Furukawa H, Todo S, Imventarza O, Casavilla A, Wu YM, Scotti-Foglieni C, Broznick Brian, Bryant J, Day R, Starzl TE (1991) Effect of cold ischemia time on the early outcome of human hepatic allografts preserved with UW solution. Transplantation 51:1000-1004
2. Todo S, Nevy J, Yanaga K, Podesta L, Gordon RD, Starzl TE (1989) Extended preservation of human liver grafts with UW solution. JAMA 261:711-714
3. Ploeg RJ, D'Alessandro AM, Knechtle SJ, Stegall MD, Pirsh JD, Hoffman RM, Saski T, Sollinger HW, Belzer FO, Kalayoglu M (1993) Risk factors for primary dysfunction after liver transplantation - a multivariate analysis. Transplantation 55:807-813
4. Poupon RE, Chretien Y, Poupon R, Paumgartner G (1993) Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy. Hepatology 17:599-604
5. Heathcote EJ, Cauch-Dudek K, Walker V, Bailey RJ, Blendis LM, Ghent CN, Michieletti P, Minuk GY, Pappas SC, Scully LJ, Steinbrecher UP, Sutherland LR, Williams CN, Witt-Sullivan H, Worobetz LJ, Milner RA, Wanless IR (1994) The canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 19:1149-1156
6. Beuers U, Spengler U, Kruis W, Aydemir Ü, Wiebecke B, Heldwein W, Weinziehl M, Pape GR, Sauerbruch T, Paumgartner G (1992) Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatoloay 16:707-714
7. Hertl M, Engelhard O, Vollmers B, Rogiers X, Jung R, Broelsch CE (1997) Donor pretreatment with hydrophilic bile salts protects the liver from preservation and reperfusion injury in the rat. Transplant Proc 29:388-389
8. Hertl M, Clausnitzer N, Rogiers X, Jung R, Broelsch CE (1997) Infusion of hydrophilic bile salts protects the liver from reperfusion injury in the rat. Transplant Proc 29:386-387
9. Hertl M, Harvey PRC, Swanson P, Howard TK, Shenoy S, West DD, Strasberg SM (1995) Evidence of preservation injury to bile ducts by bile salts in the pig and its prevention by infusions of hydrophilic bile salts. Hepatology 21:1130-1137
10. Rees GW, Trull AK, Doyle S (1995) Evaluation of an enzyme-immunometric assay for alpha-glutathione S-transferase. Ann Clin Biochem 32:575-583
11. Trull AK, Facey SP, Rees GW, Wight DGD, Noble-Jamieson G, Joughin C, Friend PJ, Alexander GJM (1994) Serum alpha-glutathione S-transferase - a sensitive marker of hepatocellular damage associated with acute liver allograft rejection. Transplantation 58:1345-1351
12. Howard TK, Goran B, Klintmalm G, Cofer J, Husberg BS, Goldstein RM, Gonwa TA (1990) The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation 49:103-107
13. Guelduetuna S, Zimmer G, Imhof M, Bhatti S, You T, Leuschner U (1993) Molecular aspects of membrane stabilization by ursodeoxycholate. Gastroenterology 104:1736-1744
14. Heuman DM (1993) Hepatoprotective properties of ursodeoxycholic acid. Gastroenterology 104:1865-1870
15. Galle PR, Theilmann L, Raedsch R, Otto G, Stiehl A (1990) Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes. Hepatology 12:486-491
16. Heuman DM, Pandak WM, Hylemon PB, Vlahcevic ZR (1991) Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: in vitro studies in rat hepatocytes and human erythrocytes. Hepatology 14:920-926
17. Guelduetuna S, Deisinger B, Weiss A, Freisleben H-J, Zimmer G, Sipos P, Leuschner U (1997) Ursodeoxycholate stabilizes phospholipid-rich membranes and mimics the effect of cholesterol: investigations on large unilamellar vesicles. Biochim Biophys Acta 1326:265-274
18. Heuman DM, Bajaj R (1994) Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts. Gastroenterology 106:1333-1341
19. Beuers U, Spengler U, Zwiebel FM, Pauletzki J, Fischer S, Paumgartner G (1992) Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease. Hepatology 15:603-608
20. Calmus Y, Gane P, Rouger P, Poupon R (1990) Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology 11:12-15
21. Ullrich D, Rating D, Schroeter W, Hanefeld F, Bircher J (1987) Treatment with ursodeoxycholic acid renders children with biliary atresia suitable for liver transplantation. Lancet 333:1324
22. Bellentani S, Tabarroni G, Barchi T, Ferretti I, Fratti N, Villa E, Manenti F (1989) Effect of ursodeoxycholic acid treatment on alanine animotransferase and gamma-glutamyltranspeptidase serum levels in patients with hypertransaminasemia. J Hepatol 8:7-12